Defence Therapeutics Inc. – Trademark Portfolio

Entity Type: 03

Defence Therapeutics Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 11 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 5 are pending. Notable registered marks include ACCUM, ACCUVAC, ACCUTRIC, ACCUTRIC-001, and ACCUTRIC-002.

1680-200 Burrard St

Vancouver BC V6C 3L6

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Defence Therapeutics Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (11 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Defence Therapeutics Inc. have?

Defence Therapeutics Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 5 pending.

What trademark classes does Defence Therapeutics Inc. file in?

Defence Therapeutics Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Defence Therapeutics Inc.'s most well-known trademarks?

Defence Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as ACCUM, ACCUVAC, ACCUTRIC, ACCUTRIC-001, and ACCUTRIC-002. These are among 8 currently registered trademarks in the portfolio.

What is Defence Therapeutics Inc.'s trademark registration success rate?

Defence Therapeutics Inc. has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 5 applications are pending review.